50 related articles for article (PubMed ID: 12853200)
21. Intestinal endotoxemia plays a central role in development of hepatopulmonary syndrome in a cirrhotic rat model induced by multiple pathogenic factors.
Zhang HY; Han DW; Su AR; Zhang LT; Zhao ZF; Ji JQ; Li BH; Ji C
World J Gastroenterol; 2007 Dec; 13(47):6385-95. PubMed ID: 18081228
[TBL] [Abstract][Full Text] [Related]
22. Modulation of pulmonary endothelial endothelin B receptor expression and signaling: implications for experimental hepatopulmonary syndrome.
Tang L; Luo B; Patel RP; Ling Y; Zhang J; Fallon MB
Am J Physiol Lung Cell Mol Physiol; 2007 Jun; 292(6):L1467-72. PubMed ID: 17337507
[TBL] [Abstract][Full Text] [Related]
23. Hepatopulmonary syndrome.
Arguedas MR; Fallon MB
Curr Treat Options Gastroenterol; 2005 Dec; 8(6):451-6. PubMed ID: 16313862
[TBL] [Abstract][Full Text] [Related]
24. Effects of nebulized N(G)-nitro-L-arginine methyl ester in patients with hepatopulmonary syndrome.
Gómez FP; Barberà JA; Roca J; Burgos F; Gistau C; Rodríguez-Roisin R
Hepatology; 2006 May; 43(5):1084-91. PubMed ID: 16628648
[TBL] [Abstract][Full Text] [Related]
25. Inhaled iloprost for hepatopulmonary syndrome: improvement of hypoxemia.
Krug S; Seyfarth HJ; Hagendorff A; Wirtz H
Eur J Gastroenterol Hepatol; 2007 Dec; 19(12):1140-3. PubMed ID: 17998841
[TBL] [Abstract][Full Text] [Related]
26. Pretreatment with N-nitro-L-arginine methyl ester improved oxygenation after inhalation of nitric oxide in newborn piglets with Escherichia coli pneumonia and sepsis.
Chang YS; Kang S; Ko SY; Park WS
J Korean Med Sci; 2006 Dec; 21(6):965-72. PubMed ID: 17179670
[TBL] [Abstract][Full Text] [Related]
27. [Hepatopulmonary syndrome in liver cirrhosis].
Culafić Dj; Perisić M; Rebić P
Srp Arh Celok Lek; 2000; 128(7-8):271-5. PubMed ID: 11089435
[TBL] [Abstract][Full Text] [Related]
28. Regulation of heme oxygenase-1 by nitric oxide during hepatopulmonary syndrome.
Carter EP; Hartsfield CL; Miyazono M; Jakkula M; Morris KG; McMurtry IF
Am J Physiol Lung Cell Mol Physiol; 2002 Aug; 283(2):L346-53. PubMed ID: 12114196
[TBL] [Abstract][Full Text] [Related]
29. Effect on dyspnoea and hypoxaemia of inhaled N(G)-nitro-L-arginine methyl ester in hepatopulmonary syndrome.
Brussino L; Bucca C; Morello M; Scappaticci E; Mauro M; Rolla G
Lancet; 2003 Jul; 362(9377):43-4. PubMed ID: 12853200
[TBL] [Abstract][Full Text] [Related]
30. [Hepatopulmonary syndrome].
Thevenot T; Pastor CM; Cervoni JP; Jacquelinet C; Nguyen-Khac E; Richou C; Heyd B; Vanlemmens C; Mantion G; Di Martino V; Cadranel J
Gastroenterol Clin Biol; 2009; 33(6-7):565-79. PubMed ID: 19481392
[TBL] [Abstract][Full Text] [Related]
31. Hepatopulmonary syndrome: role of nitric oxide and clinical aspects.
Rolla G
Dig Liver Dis; 2004 May; 36(5):303-8. PubMed ID: 15191196
[TBL] [Abstract][Full Text] [Related]
32. Hepatopulmonary syndrome-attributed extreme hypoxemia and polycythemia revealing liver cirrhosis.
Nuzzo A; Dautry R; Francoz C; Logeart D; Mégarbane B
Am J Emerg Med; 2019 Jan; 37(1):175.e1-175.e2. PubMed ID: 30269997
[TBL] [Abstract][Full Text] [Related]
33. Pharmacological treatment for hepatopulmonary syndrome.
Eshraghian A; Kamyab AA; Yoon SK
Biomed Res Int; 2013; 2013():670139. PubMed ID: 24102057
[TBL] [Abstract][Full Text] [Related]
34.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
35.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
36.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
37.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
38.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
39.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
